Stool-based biomarkers of interstitial cystitis/bladder pain syndrome

A. Braundmeier-Fleming, Nathan T. Russell, Wenbin Yang, Megan Y. Nas, Ryan E. Yaggie, Matthew Berry, Laurie Bachrach, Sarah C. Flury, Darlene S. Marko, Colleen B. Bushell, Michael E Welge, Bryan A White, Anthony J. Schaeffer, David J. Klumpp

Research output: Contribution to journalArticlepeer-review


Interstitial cystitis/bladder pain syndrome (IC) is associated with significant morbidity, yet underlying mechanisms and diagnostic biomarkers remain unknown. Pelvic organs exhibit neural crosstalk by convergence of visceral sensory pathways, and rodent studies demonstrate distinct bacterial pain phenotypes, suggesting that the microbiome modulates pelvic pain in IC. Stool samples were obtained from female IC patients and healthy controls, and symptom severity was determined by questionnaire. Operational taxonomic units (OTUs) were identified by16S rDNA sequence analysis. Machine learning by Extended Random Forest (ERF) identified OTUs associated with symptom scores. Quantitative PCR of stool DNA with species-specific primer pairs demonstrated significantly reduced levels of E. sinensis, C. aerofaciens, F. prausnitzii, O. splanchnicus, and L. longoviformis in microbiota of IC patients. These species, deficient in IC pelvic pain (DIPP), were further evaluated by Receiver-operator characteristic (ROC) analyses, and DIPP species emerged as potential IC biomarkers. Stool metabolomic studies identified glyceraldehyde as significantly elevated in IC. Metabolomic pathway analysis identified lipid pathways, consistent with predicted metagenome functionality. Together, these findings suggest that DIPP species and metabolites may serve as candidates for novel IC biomarkers in stool. Functional changes in the IC microbiome may also serve as therapeutic targets for treating chronic pelvic pain.

Original languageEnglish (US)
Article number26083
JournalScientific reports
StatePublished - May 18 2016

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Stool-based biomarkers of interstitial cystitis/bladder pain syndrome'. Together they form a unique fingerprint.

Cite this